| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/21/2011 | US20110091473 Novel antibody therapies |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091468 Connective tissue growth factor antibodies |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091443 Heparin-conjugated fibrin gel and method and kit for preparing same |
| 04/21/2011 | US20110091436 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091421 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases |
| 04/21/2011 | US20110091411 Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091378 Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | DE102009049702A1 Verwendung von Lactoferrin und Lactoferrin enthaltende Zusammensetzungen Use of lactoferrin and lactoferrin containing compositions |
| 04/21/2011 | DE102009049679A1 Pyrazolopyrimidinderivate Pyrazolopyrimidinderivate |
| 04/21/2011 | CA2777595A1 Allergy treatment using acid treated aqueous whey protein extract |
| 04/21/2011 | CA2777290A1 Process for the preparation of f-series prostaglandins |
| 04/21/2011 | CA2777250A1 Na-k pump modulation |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311825A1 Pyrimidineamines as angiogenesis modulators |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311811A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311799A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311798A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311797A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311796A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311494A1 Histone modification inhibitor specific to target gene |
| 04/20/2011 | EP2311473A1 Lactobacillus plantarum strains as probiotics |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2311432A1 Prevention and reduction of blood loss |
| 04/20/2011 | EP2310385A2 Solid pharmaceutical composition |
| 04/20/2011 | EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 04/20/2011 | EP2310041A2 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 04/20/2011 | EP2310039A1 Fgf-9 and its use relating to blood vessels |
| 04/20/2011 | EP2310004A1 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |
| 04/20/2011 | EP2309849A1 Method of treating traumatic brain injury |
| 04/20/2011 | EP1680140B1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/20/2011 | EP1647555B1 The c-glycosylisoflavones having alkylaminoalkoxyl substituent, the preparation and the use of the same |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 04/20/2011 | CN1985833B Use of estrone derivative EA204 in preparing vascular smooth muscle relaxant |
| 04/20/2011 | CN1928111B Correlation analysis of circulation endothelium progenitor cell and coronary artery pathological changes |
| 04/20/2011 | CN1872107B Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application |
| 04/20/2011 | CN1839866B Medicinal composition containing breviscapine |
| 04/20/2011 | CN1824647B Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
| 04/20/2011 | CN1771949B Soft nimodipine capsule and its preparation |
| 04/20/2011 | CN102026995A 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 04/20/2011 | CN102026986A Hexafluoroisopropanol derivatives |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026664A Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 04/20/2011 | CN102026655A Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| 04/20/2011 | CN102026638A A combination drug for treating vascular disorder |
| 04/20/2011 | CN102026629A Transdermally absorbable preparation |
| 04/20/2011 | CN102021184A Antigenic polypeptides |
| 04/20/2011 | CN102021160A Snake venom serine protease and coding gene and application thereof |
| 04/20/2011 | CN102021101A Healthy wine for preventing and treating cardiovascular and cerebrovascular diseases |
| 04/20/2011 | CN102020699A Anti-platelet aggregation peptide and application thereof |
| 04/20/2011 | CN102020645A Pyrazolopyrimidinone derivatives and pharmaceutical salts, preparation method and application thereof |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020623A Butterbur extract as well as preparation method and application thereof |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN102020602A Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition |
| 04/20/2011 | CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020521A Preparation mode and application of deuterium substituted Chinese herbal monomer |
| 04/20/2011 | CN102018959A Method and reagent for preventing and treating heart disease |
| 04/20/2011 | CN102018950A Drug for treating hyperlipidemia, hyperviscosity, hypertension and coronary heart diseases |
| 04/20/2011 | CN102018949A Traditional Chinese medicine composition for treating vertigo |
| 04/20/2011 | CN102018934A Traditional Chinese medicine for treating heart diseases |
| 04/20/2011 | CN102018915A Traditional Chinese medicine for treating acral thanatosis caused by diabetes |
| 04/20/2011 | CN102018914A Traditional Chinese medicinal composition used for curing arteriosclerosis |
| 04/20/2011 | CN102018896A Chinese medicinal health-care tea with effects of nourishing lung and reducing blood pressure |
| 04/20/2011 | CN102018892A Chinese medicinal composition for treating vertigo caused by hypertension |
| 04/20/2011 | CN102018891A Chinese medicinal preparation for treating hypertension |
| 04/20/2011 | CN102018877A Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
| 04/20/2011 | CN102018867A Medical composition containing chondroitin sulfuric acid and/or medical salt thereof and garlic oil |
| 04/20/2011 | CN102018863A Medicine paste with functions of diminishing inflammation, relieving pain, activating blood circulation and dissipating blood stasis and manufacturing method thereof |
| 04/20/2011 | CN102018860A Household preparation formula for treating coronary heart disease and preparation method thereof |
| 04/20/2011 | CN102018839A Medicinal wine for dissolving thrombus and prolonging life |
| 04/20/2011 | CN102018836A Chinese traditional medicine for treating mixed hemorrhoids |
| 04/20/2011 | CN102018830A Traditional Chinese medicine for treating fundus hemorrhage |
| 04/20/2011 | CN102018829A Traditional Chinese medicinal capsules used for treating apoplexia and preparation method thereof |
| 04/20/2011 | CN102018823A Composite preparation containing phospholipid, alpha-linolenic acid, gamma-linolenic acid and tomato extract |
| 04/20/2011 | CN102018787A Blood pressure lowering capsules and preparation process thereof |
| 04/20/2011 | CN102018786A Formula of tea used for treating hypertension and a preparation method thereof |
| 04/20/2011 | CN102018782A Compound cutch sarcogenic oil and preparation method thereof |
| 04/20/2011 | CN102018746A Diet therapy formula for treating hypertension and preparation method thereof |
| 04/20/2011 | CN102018741A Spanishneedles herb total flavone extract as well as preparation technology and preparation thereof |
| 04/20/2011 | CN102018740A Medicinal composition containing extracts of leaves of helianthus and application of the same |
| 04/20/2011 | CN102018732A Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract |